The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.

Lubin, founder and CEO of a four-year-old online fashion marketplace and the Democratic challenger to U.S. Rep. Andrew ...

The CDC recommends that immunocompromised people and those age 65 and older should get a second dose of the 2024-2025 COVID ...

Clinical trials of single-agent targeted drugs have shown limited efficacy. In the only trial of single-agent immunotherapy ...

In the wake of the elimination diets, 38% of the parents reported no improvement in their child’s AD, 35% reported a 25% ...

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...

A key panel of U.S. health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

As more Big Pharma companies have launched direct-to-consumer telehealth platforms, lawmakers have raised concerns they might ...

These are four high-yield stocks that top-flight hedge fund managers have been buying as they wait for interest rates to drop ...

Housed in a 53′, state-of-the-art, double expandable trailer on wheels, Pfizer School of Science Mobile Experience will travel to select parts of the country throughout 2024 and 2025 to bring the ...

The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that adults over 65 and immunocompromised people get ...